Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlphaMind Brands is a Canada- and U.S.-focused health and wellness company best known for mushroom-based natural health products and early research interest in psilocybin-derived pharmaceutical applications. The company has marketed legal functional mushroom products such as cordyceps, lion's mane, chaga, reishi, shiitake, and oyster mushroom formulations, while also describing university-linked R&D around psychedelic compounds. AlphaMind Brands was acquired by Hollister Biosciences in 2020 and subsequently operated as a subsidiary. It appears to be more of a consumer health and emerging psychedelic wellness asset than a traditional clinical-stage biopharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlphaMind.